Trials / Unknown
UnknownNCT02594306
Brain Electrophysiological Study(EEG/ERP) on Opiate Addicts Treating by Bilateral NAc/ALIC Deep Brain Stimulation
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Tang-Du Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
Drug addiction is compulsive and spontaneous drug-taking behavior which is characterized by non-medical usage, long and repeated exposure to addictive drugs and gradually increasing drug-taking dosage and frequency,and become a main threat against human being's public health, economic development and social safety.
Detailed description
Effective treatments for severe drug addiction are limited. China centers employing compulsory detoxification, reported a 3 year abstinence rate of only 15%. For the methadone maintenance therapy, relapse often occurs promptly after cessation of methadone. A Malaysian reports about taking naltrexone or buprenorphine treating,showed average relapsed time of 2 or 3 months,respectively. Assessment for psychological craving degree of addiction patients is also a difficult thing.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Emotional pictures stimulation system | Emotional pictures stimulation system is component of neutral and drug-related images. |
| PROCEDURE | Deep brain stimulation | Deep brain stimulation of bilateral NAc/ALIC |
| PROCEDURE | adjacent contact stimulation | The electrode of deep brain stimulation has four contacts.We stimulate one contact,and record the local field potential of other contacts. |
| PROCEDURE | microelectrode | We put the microelectrodes into bilateral nucleus accumbens and anterior limb of the internal capsule,to record the waveform of bilateral NAc/ALIC. |
Timeline
- Start date
- 2015-10-01
- Primary completion
- 2016-11-01
- Completion
- 2016-11-01
- First posted
- 2015-11-03
- Last updated
- 2016-02-19
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02594306. Inclusion in this directory is not an endorsement.